Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)

Completed · Phase 3 · Has a placebo group

Conditions studied: Non-Constipation Irritable Bowel Syndrome

In brief

To evaluate the efficacy of a 14-day course of rifaximin given 3 times a day vs. placebo in providing adequate relief of IBS symptoms.

Key facts

Study ID

NCT00724126

Run by

Bausch Health Americas, Inc.

People needed

637

Starts

2008-07-01

Expected to finish

2009-09-01

Last updated by the study team

2019-11-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed IBS diagnosis per Rome II criteria for diagnosis of IBS.
• Colonoscopy within 2 years as part of IBS diagnostic evaluation.
• Has active symptoms of non-constipation IBS at baseline as measured by average daily scores for abdominal pain/discomfort, bloating, and stool consistency.

You may not qualify if…

• Symptoms of constipation.
• History of other gastrointestinal diseases.
• Type 1 or 2 diabetes.
• Lactose intolerance not controlled by lactose-free diet.

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Huntsville, Alabama, United States
• Study site — Tempe, Arizona, United States
• Study site — Anaheim, California, United States
• Study site — Carmichael, California, United States
• Study site — Chula Vista, California, United States
• Study site — Concord, California, United States
• Study site — Garden Grove, California, United States
• Study site — Laguna Hills, California, United States
• Study site — Lakewood, California, United States
• Study site — Los Angeles, California, United States
• Study site — Monterey, California, United States
• Study site — Orange, California, United States
• Study site — Roseville, California, United States
• Study site — San Carlos, California, United States
• Study site — San Francisco, California, United States
• Study site — Bristol, Connecticut, United States
• Study site — Hamden, Connecticut, United States
• Study site — Newark, Delaware, United States
• Study site — Boca Raton, Florida, United States
• Study site — Hollywood, Florida, United States
• Study site — Largo, Florida, United States
• Study site — New Port Richey, Florida, United States
• Study site — New Smyrna Beach, Florida, United States
• Study site — Anniston, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.